Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer letters

Showing results (171-180 of 17,056) with videos related to

Pageof 1,706
Sort By:
Cancer Letters|December 26, 2013
Attenuation of TGF-β signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine modelTanuka Biswas, Xiang Gu, Junhua Yang, et al.
Cancer Letters|August 17, 2014
Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignanciesHaijun Chen, Yu Gao, Jianlei Wu, et al.
Cancer Letters|August 17, 2014
Molecular mechanisms of endometrial stromal sarcoma and undifferentiated endometrial sarcoma as premises for new therapeutic strategiesAndelko Hrzenjak, Martina Dieber-Rotheneder, Farid Moinfar, et al.
Cancer Letters|August 19, 2014
Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)Fei Ma, Huihui Li, Haijuan Wang, et al.
Cancer Letters|August 19, 2014
Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cellsSung-Moo Kim, Jong Hyun Lee, Gautam Sethi, et al.
Cancer Letters|August 19, 2014
Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumorsJing Nie, Lin Liu, Xiang Li, et al.
Cancer Letters|December 17, 2013
Mesenchymal stromal cell ciliogenesis is abrogated in response to tumor necrosis factor-α and requires NF-κB signalingAmélie Vézina, Eric Vaillancourt-Jean, Stéphanie Albarao, et al.
Cancer Letters|December 17, 2013
LRH1 as a driving factor in pancreatic cancer growthQiushi Lin, Arihiro Aihara, Waihong Chung, et al.
Cancer Letters|December 28, 2013
Bystander effects as manifestation of intercellular communication of DNA damage and of the cellular oxidative statusHolger Klammer, Emil Mladenov, Fanghua Li, et al.
Cancer Letters|July 13, 2014
Development of a prediction model for lymph node metastasis in luminal A subtype breast cancer: the possibility to omit sentinel lymph node biopsyChiaki Nakauchi, Yasuto Naoi, Kenzo Shimazu, et al.
Pageof 1,706

Showing results (171-180 of 17,056) with videos related to

Sort By:
Pageof 1,706
Cancer Letters|December 26, 2013
Attenuation of TGF-β signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine modelTanuka Biswas, Xiang Gu, Junhua Yang, et al.
Cancer Letters|August 17, 2014
Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignanciesHaijun Chen, Yu Gao, Jianlei Wu, et al.
Cancer Letters|August 17, 2014
Molecular mechanisms of endometrial stromal sarcoma and undifferentiated endometrial sarcoma as premises for new therapeutic strategiesAndelko Hrzenjak, Martina Dieber-Rotheneder, Farid Moinfar, et al.
Cancer Letters|August 19, 2014
Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)Fei Ma, Huihui Li, Haijuan Wang, et al.
Cancer Letters|August 19, 2014
Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cellsSung-Moo Kim, Jong Hyun Lee, Gautam Sethi, et al.
Cancer Letters|August 19, 2014
Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumorsJing Nie, Lin Liu, Xiang Li, et al.
Cancer Letters|December 17, 2013
Mesenchymal stromal cell ciliogenesis is abrogated in response to tumor necrosis factor-α and requires NF-κB signalingAmélie Vézina, Eric Vaillancourt-Jean, Stéphanie Albarao, et al.
Cancer Letters|December 17, 2013
LRH1 as a driving factor in pancreatic cancer growthQiushi Lin, Arihiro Aihara, Waihong Chung, et al.
Cancer Letters|December 28, 2013
Bystander effects as manifestation of intercellular communication of DNA damage and of the cellular oxidative statusHolger Klammer, Emil Mladenov, Fanghua Li, et al.
Cancer Letters|July 13, 2014
Development of a prediction model for lymph node metastasis in luminal A subtype breast cancer: the possibility to omit sentinel lymph node biopsyChiaki Nakauchi, Yasuto Naoi, Kenzo Shimazu, et al.
Pageof 1,706